The Cellular and Molecular Pathology Biobanking Sample Quality Improvement Tool: A Guide for Improving the Quality of Tissue Collections for Biomedical Research and Clinical Trials in Cancer
Restricted accessBrief reportFirst published online February, 2021
The Cellular and Molecular Pathology Biobanking Sample Quality Improvement Tool: A Guide for Improving the Quality of Tissue Collections for Biomedical Research and Clinical Trials in Cancer
MacklinPS, HallA, LeeJ, et al.Barriers to the release of human tissue for clinical trials research in the UK: a national survey of cellular pathology laboratories on behalf of the National Cancer Research Institute's Cellular Molecular Pathology (CM-Path) initiative. J Clin Pathol, 2019; 72:52–57.
2.
BakerAF, DragovichT, IhleNT, WilliamsR, Fenoglio-PreiserC, PowisG. Stability of phosphoprotein as a biological marker of tumor signaling. Clin Cancer Res, 2005; 11:4338–4340.
3.
EspinaV, EdmistonKH, HeibyM, et al.A portrait of tissue phosphoprotein stability in the clinical tissue procurement process. Mol Cell Proteom, 2008; 7:1998–2018.
4.
VassilakopoulouM, ParisiF, SiddiquiS, et al.Preanalytical variables and phosphoepitope expression in FFPE tissue: quantitative epitope assessment after variable cold ischemic time. Lab Invest, 2015; 95:334–341.
5.
HolubP, SwertzM, ReihsR, van EnckevortD, MüllerH, LittonJ-E. BBMRI-ERIC directory: 515 biobanks with over 60 million biological samples. Biopreserv Biobank, 2016; 14:559–562.
6.
HartmanV, Castillo-PelayoT, BabinszkyS, et al.Is your biobank up to standards? A review of the national canadian tissue repository network required operational practice standards and the controlled documents of a certified biobank. Biopreserv Biobank, 2018; 16:36–41.
7.
O'DonoghueS, MatzkeL, WatsonP. ISBER best practice-based education: ISBER-Canadian tissue repository network introduction to biobanking. Biopreserv Biobank, 2018; 16:13–15.
8.
MooreHM, KellyAB, JewellSD, et al.Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol, 2011; 119:92–101.
LingR, RushA, CarterC, et al.An Australian biobank certification scheme: A study of economic costs to participating biobanks. Biopreserv Biobank, 2018; 16:53–58.
11.
McCallSJ, BrantonPA, BlancVM, et al.The college of American Pathologists Biorepository Accreditation Program: Results from the first 5 years. Biopreserv Biobank, 2018; 16:16–22.
12.
QuinlanPR, GrovesM, JordanLB, StobartH, PurdieCA, ThompsonAM. The informatics challenges facing biobanks: A perspective from a United Kingdom Biobanking Network. Biopreserv Biobank, 2015; 13:363–370.
13.
QuinlanPR, MistryG, BullbeckH, CarterA. A data standard for sourcing fit-for-purpose biological samples in an integrated virtual network of biobanks. Biopreserv Biobank, 2014; 12:184–191.
14.
CuttsRJ, Guerra-AssuncaoJA, GadaletaE, Dayem UllahAZ, ChelalaC. BCCTBbp: the Breast Cancer Campaign Tissue Bank bioinformatics portal. Nucleic Acids Res, 2015; 43(Database issue):D831–D836.
15.
JacobsG, WolfA, KrawczakM, LiebW. Biobanks in the era of digital medicine. Clin Pharmacol Ther, 2018; 103:761–762.
